Gasmi Mehdi 4
4 · Adverum Biotechnologies, Inc. · Filed May 14, 2021
Insider Transaction Report
Form 4
Gasmi Mehdi
VP, Pharmaceutical Development
Transactions
- Award
Stock Option (Right to Buy)
2021-05-12+40,000→ 40,000 totalExercise: $3.70Exp: 2031-05-11→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of May 12, 2022 or the 2022 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.